90 related articles for article (PubMed ID: 36328268)
1. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets.
Hussen BM; Abdullah ST; Rasul MF; Salihi A; Ghafouri-Fard S; Hidayat HJ; Taheri M
Front Mol Biosci; 2021; 8():764025. PubMed ID: 34778378
[TBL] [Abstract][Full Text] [Related]
2. Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer.
Omran MM; Fouda MS; Mekkawy SA; Tabll AA; Abdelaziz AG; Omran AM; Emran TM
Technol Cancer Res Treat; 2024; 23():15330338241254061. PubMed ID: 38794896
[TBL] [Abstract][Full Text] [Related]
3. GEnDDn: An lncRNA-Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network.
Peng L; Ren M; Huang L; Chen M
Interdiscip Sci; 2024 May; ():. PubMed ID: 38733474
[TBL] [Abstract][Full Text] [Related]
4. Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review.
Nie C; Shaw I; Chen C
J Pharm Anal; 2023 Dec; 13(12):1429-1451. PubMed ID: 38223444
[TBL] [Abstract][Full Text] [Related]
5. Exploring the time-dependent regulatory potential of microRNAs in breast cancer cells treated with proteasome inhibitors.
Katsaraki K; Kontos CK; Ardavanis-Loukeris G; Tzovaras AA; Sideris DC; Scorilas A
Clin Transl Oncol; 2024 May; 26(5):1256-1267. PubMed ID: 38038871
[TBL] [Abstract][Full Text] [Related]
6. CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens.
Ibragimova MK; Kravtsova EA; Tsyganov MM; Litviakov NV
Acta Naturae; 2023; 15(3):66-74. PubMed ID: 37908774
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.
Abduh MS
Int J Nanomedicine; 2023; 18():5713-5732. PubMed ID: 37849642
[TBL] [Abstract][Full Text] [Related]
8. Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.
Deng X; Wang J; Lu C; Zhou Y; Shen L; Ge A; Fan H; Liu L
Front Pharmacol; 2023; 14():1226629. PubMed ID: 37818185
[TBL] [Abstract][Full Text] [Related]
9. The journey of boswellic acids from synthesis to pharmacological activities.
Ragab EA; Abd El-Wahab MF; Doghish AS; Salama RM; Eissa N; Darwish SF
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1477-1504. PubMed ID: 37740772
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
[TBL] [Abstract][Full Text] [Related]
12. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review.
Ismail A; El-Mahdy HA; Abulsoud AI; Sallam AM; Eldeib MG; Elsakka EGE; Zaki MB; Doghish AS
Int J Biol Macromol; 2023 Jan; 224():1541-1565. PubMed ID: 36328268
[TBL] [Abstract][Full Text] [Related]
13. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers.
El-Mahdy HA; Sallam AM; Ismail A; Elkhawaga SY; Elrebehy MA; Doghish AS
Pathol Res Pract; 2022 May; 233():153886. PubMed ID: 35405621
[TBL] [Abstract][Full Text] [Related]
14. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
[TBL] [Abstract][Full Text] [Related]
15. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.
Fathi D; Elballal MS; Elesawy AE; Abulsoud AI; Elshafei A; Elsakka EGE; Ismail A; El-Mahdy HA; Elrebehy MA; Doghish AS
Life Sci; 2023 Jun; 322():121667. PubMed ID: 37023952
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
